People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

According to the Association’s 2025 Statistics Update: ...

Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...

They’re expensive and aren’t a short-term fix, but Ozempic and Wegovy show great promise in regulating weight. | Opinion ...

FibroScan overestimated advanced fibrosis and cirrhosis in patients with class 3 obesity and metabolic dysfunction-associated steatotic liver disease.

This study shows that the SAAR diet regulates glucose and lipid metabolism to support weight control without impacting ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

A new study says that married men may have triple the risk of obesity, compared to unmarried men, and that marriage seems to ...

Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...

Wedded to weight gain? New research shows a shocking link between marriage and excess pounds. A team from the National ...

Objective This study aimed to identify body mass index (BMI) growth trajectories from birth to 24 months of age and examine ...

For patients who are significantly overweight — the path forward to losing it may include a decision between drugs or surgery ...